vs

Side-by-side financial comparison of Bunge Global (BG) and STEPAN CO (SCL). Click either name above to swap in a different company.

Bunge Global is the larger business by last-quarter revenue ($4.9B vs $553.9M, roughly 8.8× STEPAN CO). Bunge Global runs the higher net margin — 1.9% vs 0.9%, a 1.0% gap on every dollar of revenue. On growth, Bunge Global posted the faster year-over-year revenue change (22.2% vs 5.4%). Bunge Global produced more free cash flow last quarter ($809.0M vs $25.4M). Over the past eight quarters, Bunge Global's revenue compounded faster (11.3% CAGR vs 0.2%).

Bunge Global SA (BUN-ghee) is a global agribusiness and food company, incorporated in Geneva, Switzerland and headquartered in St. Louis, Missouri, United States.

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

BG vs SCL — Head-to-Head

Bigger by revenue
BG
BG
8.8× larger
BG
$4.9B
$553.9M
SCL
Growing faster (revenue YoY)
BG
BG
+16.8% gap
BG
22.2%
5.4%
SCL
Higher net margin
BG
BG
1.0% more per $
BG
1.9%
0.9%
SCL
More free cash flow
BG
BG
$783.6M more FCF
BG
$809.0M
$25.4M
SCL
Faster 2-yr revenue CAGR
BG
BG
Annualised
BG
11.3%
0.2%
SCL

Income Statement — Q4 2025 vs Q4 2025

Metric
BG
BG
SCL
SCL
Revenue
$4.9B
$553.9M
Net Profit
$95.0M
$5.0M
Gross Margin
20.7%
9.3%
Operating Margin
1.8%
1.9%
Net Margin
1.9%
0.9%
Revenue YoY
22.2%
5.4%
Net Profit YoY
-84.2%
49.4%
EPS (diluted)
$-0.02
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BG
BG
SCL
SCL
Q4 25
$4.9B
$553.9M
Q3 25
$4.4B
$590.3M
Q2 25
$4.0B
$594.7M
Q1 25
$3.7B
$593.3M
Q4 24
$4.0B
$525.6M
Q3 24
$3.9B
$546.8M
Q2 24
$3.7B
$556.4M
Q1 24
$3.9B
$551.4M
Net Profit
BG
BG
SCL
SCL
Q4 25
$95.0M
$5.0M
Q3 25
$166.0M
$10.8M
Q2 25
$354.0M
$11.3M
Q1 25
$201.0M
$19.7M
Q4 24
$602.0M
$3.4M
Q3 24
$221.0M
$23.6M
Q2 24
$70.0M
$9.5M
Q1 24
$244.0M
$13.9M
Gross Margin
BG
BG
SCL
SCL
Q4 25
20.7%
9.3%
Q3 25
24.3%
12.0%
Q2 25
18.4%
12.1%
Q1 25
16.3%
12.7%
Q4 24
27.0%
10.8%
Q3 24
19.9%
13.8%
Q2 24
17.8%
12.5%
Q1 24
22.2%
12.7%
Operating Margin
BG
BG
SCL
SCL
Q4 25
1.8%
1.9%
Q3 25
6.2%
3.7%
Q2 25
12.3%
3.0%
Q1 25
7.8%
4.8%
Q4 24
18.3%
1.5%
Q3 24
8.3%
4.4%
Q2 24
2.8%
3.4%
Q1 24
9.4%
3.7%
Net Margin
BG
BG
SCL
SCL
Q4 25
1.9%
0.9%
Q3 25
3.8%
1.8%
Q2 25
8.8%
1.9%
Q1 25
5.5%
3.3%
Q4 24
15.0%
0.6%
Q3 24
5.7%
4.3%
Q2 24
1.9%
1.7%
Q1 24
6.2%
2.5%
EPS (diluted)
BG
BG
SCL
SCL
Q4 25
$-0.02
$0.22
Q3 25
$0.84
$0.47
Q2 25
$2.61
$0.50
Q1 25
$1.48
$0.86
Q4 24
$4.27
$0.14
Q3 24
$1.56
$1.03
Q2 24
$0.48
$0.42
Q1 24
$1.68
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BG
BG
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$2.0B
$132.7M
Total DebtLower is stronger
$10.2B
$626.7M
Stockholders' EquityBook value
$15.9B
$1.2B
Total Assets
$44.5B
$2.4B
Debt / EquityLower = less leverage
0.64×
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BG
BG
SCL
SCL
Q4 25
$2.0B
$132.7M
Q3 25
$3.2B
$118.5M
Q2 25
$7.1B
$88.9M
Q1 25
$3.9B
$107.5M
Q4 24
$3.8B
$99.7M
Q3 24
$3.0B
$147.3M
Q2 24
$1.3B
$124.7M
Q1 24
$3.1B
$125.8M
Total Debt
BG
BG
SCL
SCL
Q4 25
$10.2B
$626.7M
Q3 25
$11.1B
$655.5M
Q2 25
$7.7B
$658.0M
Q1 25
$5.4B
$659.3M
Q4 24
$5.4B
$625.4M
Q3 24
$5.4B
$688.5M
Q2 24
$4.1B
$657.1M
Q1 24
$4.1B
$646.0M
Stockholders' Equity
BG
BG
SCL
SCL
Q4 25
$15.9B
$1.2B
Q3 25
$15.8B
$1.2B
Q2 25
$10.9B
$1.2B
Q1 25
$10.6B
$1.2B
Q4 24
$9.9B
$1.2B
Q3 24
$10.1B
$1.2B
Q2 24
$10.0B
$1.2B
Q1 24
$10.6B
$1.2B
Total Assets
BG
BG
SCL
SCL
Q4 25
$44.5B
$2.4B
Q3 25
$46.3B
$2.4B
Q2 25
$31.2B
$2.4B
Q1 25
$26.7B
$2.4B
Q4 24
$24.9B
$2.3B
Q3 24
$25.3B
$2.4B
Q2 24
$24.4B
$2.3B
Q1 24
$25.8B
$2.4B
Debt / Equity
BG
BG
SCL
SCL
Q4 25
0.64×
0.50×
Q3 25
0.71×
0.53×
Q2 25
0.71×
0.53×
Q1 25
0.51×
0.55×
Q4 24
0.54×
0.53×
Q3 24
0.54×
0.56×
Q2 24
0.41×
0.55×
Q1 24
0.39×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BG
BG
SCL
SCL
Operating Cash FlowLast quarter
$1.3B
$60.0M
Free Cash FlowOCF − Capex
$809.0M
$25.4M
FCF MarginFCF / Revenue
16.6%
4.6%
Capex IntensityCapex / Revenue
11.0%
6.3%
Cash ConversionOCF / Net Profit
14.18×
11.99×
TTM Free Cash FlowTrailing 4 quarters
$-879.0M
$25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BG
BG
SCL
SCL
Q4 25
$1.3B
$60.0M
Q3 25
$854.0M
$69.8M
Q2 25
$-1.1B
$11.2M
Q1 25
$-285.0M
$6.9M
Q4 24
$1.1B
$68.3M
Q3 24
$1.3B
$22.7M
Q2 24
$-1.5B
$29.5M
Q1 24
$994.0M
$41.6M
Free Cash Flow
BG
BG
SCL
SCL
Q4 25
$809.0M
$25.4M
Q3 25
$385.0M
$40.2M
Q2 25
$-1.5B
$-14.4M
Q1 25
$-595.0M
$-25.8M
Q4 24
$564.0M
$32.1M
Q3 24
$973.0M
$-4.0M
Q2 24
$-1.8B
$-208.0K
Q1 24
$758.0M
$11.4M
FCF Margin
BG
BG
SCL
SCL
Q4 25
16.6%
4.6%
Q3 25
8.8%
6.8%
Q2 25
-36.8%
-2.4%
Q1 25
-16.2%
-4.3%
Q4 24
14.1%
6.1%
Q3 24
25.1%
-0.7%
Q2 24
-47.4%
-0.0%
Q1 24
19.2%
2.1%
Capex Intensity
BG
BG
SCL
SCL
Q4 25
11.0%
6.3%
Q3 25
10.7%
5.0%
Q2 25
10.1%
4.3%
Q1 25
8.5%
5.5%
Q4 24
12.2%
6.9%
Q3 24
9.1%
4.9%
Q2 24
8.0%
5.3%
Q1 24
6.0%
5.5%
Cash Conversion
BG
BG
SCL
SCL
Q4 25
14.18×
11.99×
Q3 25
5.14×
6.44×
Q2 25
-3.03×
0.99×
Q1 25
-1.42×
0.35×
Q4 24
1.75×
20.38×
Q3 24
6.00×
0.96×
Q2 24
-21.06×
3.10×
Q1 24
4.07×
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BG
BG

Other Oilseeds Processing And Refining$4.6B95%
Other$251.0M5%
Other Products$3.0M0%

SCL
SCL

Surfactants$401.8M73%
Polymers$131.7M24%
Specialty Products$20.4M4%

Related Comparisons